The FDA approved Pentax’s ED34-i10T, a duodenoscope with a disposable, single-use distal cap.
Allergan’s board of directors authorized the company to buy back $2 billion in stock, while also committing to increasing its quarterly dividends and reaffirming its decision to pay down $3.75 billion in debt by 2018.
The FDA approved Bracco Diagnostics’ Tagitol V oral suspension for adult patients undergoing virtual colonoscopy.
A study from England-based Oxford University further validated Medial EarlySign’s ColonFlag.
Landos Biopharma completed a series A financing round raising $10 million.
More articles on gastroenterology:
Landos Biopharma raises $10M in series A funding round — 3 insights
GI leader to know: Dr. Nicole Griglione of GI Associates
Stock market week-in-review for 5 large GI companies — Sept. 18-22
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.